CN Patent

CN100563653C — 具有β-内酰胺酶抑制剂活性的杂环化合物

Assigned to AstraZeneca SAS · Expires 2009-12-02 · 16y expired

What this patent protects

本发明涉及式(I)化合物及其可药用盐在制备用于抑制致病菌产生β-内酰胺酶的药物中的用途。

USPTO Abstract

本发明涉及式(I)化合物及其可药用盐在制备用于抑制致病菌产生β-内酰胺酶的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN100563653C
Jurisdiction: CN
Classification: —
Expires: 2009-12-02
Drug substance claim: No
Drug product claim: No
Assignee: AstraZeneca SAS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.